A multicenter, randomized, phase II study of the combination of docetaxel (Taxotere) and concomitant radiotherapy with or without cisplatin in patients with locally advanced head and neck cancer.

Trial Profile

A multicenter, randomized, phase II study of the combination of docetaxel (Taxotere) and concomitant radiotherapy with or without cisplatin in patients with locally advanced head and neck cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Mar 2010

At a glance

  • Drugs Cisplatin; Docetaxel
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 08 Oct 2008 Actual end date changed from Oct 2007 to May 2006 added as reported by ClinicalTrials.gov.
    • 05 Oct 2008 Actual number of patients (86) added as reported by CT.gov
    • 20 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top